New study tests which drug combo best protects kidneys in hypertensive patients
Disease control
Recruiting now
This Phase 3 trial compares two treatments for people with high blood pressure and chronic kidney disease: finerenone versus a fixed-dose combination of torsemide and spironolactone. The study will enroll 30 adults to see which approach better lowers blood pressure, reduces prote…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC